ArticleCurrent medical science2023

Gefapixant, a Novel P2X3 Antagonist, Protects against Post Myocardial Infarction Cardiac Dysfunction and Remodeling Via Suppressing NLRP3 Inflammasome.

Yan-Zhao Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.